News

U.S. Physical Therapy said on February 27, 2024 that its board of directors declared a regular quarterly dividend of $0.44 per share ($1.76 annualized). Previously, the company paid $0.43 per share.

Shares must be purchased before the ex-div date of March 11, 2024 to qualify for the dividend. Shareholders of record as of March 12, 2024 will receive the payment on April 5, 2024.

At the current share price of $104.56 / share, the stock's dividend yield is 1.68%.

Looking back five years and taking a sample every week, the average dividend yield has been 1.47%, the lowest has been 0.82%, and the highest has been 2.29%. The standard deviation of yields is 0.37 (n=207).

The current dividend yield is 0.57 standard deviations above the historical average.

Additionally, the company's dividend payout ratio is 0.93. The payout ratio tells us how much of a company's income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company's income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.

The company's 3-Year dividend growth rate is 0.26%, demonstrating that it has increased its dividend over time.

What is the Fund Sentiment?

There are 470 funds or institutions reporting positions in U.S. Physical Therapy. This is a decrease of 8 owner(s) or 1.67% in the last quarter. Average portfolio weight of all funds dedicated to USPH is -12.10%, a decrease of 5,489.38%. Total shares owned by institutions increased in the last three months by 0.08% to 19,220K shares. The put/call ratio of USPH is 1.15, indicating a bearish outlook.

Analyst Price Forecast Suggests 6.72% Upside

As of February 24, 2024, the average one-year price target for U.S. Physical Therapy is 111.59. The forecasts range from a low of 99.99 to a high of $126.00. The average price target represents an increase of 6.72% from its latest reported closing price of 104.56.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for U.S. Physical Therapy is 639MM, an increase of 6.76%. The projected annual non-GAAP EPS is 3.26.

What are Other Shareholders Doing?

Kayne Anderson Rudnick Investment Management holds 1,366K shares representing 9.11% ownership of the company. In it's prior filing, the firm reported owning 1,493K shares, representing a decrease of 9.32%. The firm decreased its portfolio allocation in USPH by 18.51% over the last quarter.

IJR - iShares Core S&P Small-Cap ETF holds 1,003K shares representing 6.69% ownership of the company. In it's prior filing, the firm reported owning 1,012K shares, representing a decrease of 0.88%. The firm decreased its portfolio allocation in USPH by 12.95% over the last quarter.

PSGAX - Virtus KAR Small-Cap Growth Fund holds 932K shares representing 6.22% ownership of the company. In it's prior filing, the firm reported owning 1,044K shares, representing a decrease of 12.13%. The firm decreased its portfolio allocation in USPH by 9.63% over the last quarter.

T. Rowe Price Investment Management holds 761K shares representing 5.08% ownership of the company. In it's prior filing, the firm reported owning 747K shares, representing an increase of 1.93%. The firm decreased its portfolio allocation in USPH by 4.77% over the last quarter.

CCVAX - Calvert Small-Cap Fund holds 753K shares representing 5.02% ownership of the company. In it's prior filing, the firm reported owning 680K shares, representing an increase of 9.62%. The firm increased its portfolio allocation in USPH by 5.85% over the last quarter.

U.S. Physical Therapy Background Information
(This description is provided by the company.)

Founded in 1990, U.S. Physical Therapy, Inc. operates 548 outpatient physical therapy clinics in 39 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention business which provides onsite services for clients' employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.

Additional reading:

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.